Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

By Daniel Weintraub, J. Koester, Marc N. Potenza, A. Siderowf, M. Stacy, Valerie Voon, Jacqueline Whetteckey, Glen Wunderlich, A. Lang. Archives of Neurology, 2010

1,443 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Epidemiology, Neurology

View Paper: https://www.semanticscholar.org/paper/a80a4fa04c4e2bd5757800902570a8d66c3e602a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Daniel Weintraub

Citations in the corpus

• The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease (2011, methodology): “Weintraub et al. (2010)19 conducted an 8-week, randomized, placebo-controlled study of atomoxetine (an NRI) for the treatment of clinically significant depressive symptoms in 55 subjects with PD and moderate depression as defined by a score of 22 on the Inventory of Depressive…”